Global Life Sciences - progress in making their websites accessible

16 Jun 2020 | Index | Accessibility

Adam Turner
  • Tweet this item
  • share this item on Linkedin

At Sitemorse we published our 2020 Q2 Global Life Sciences INDEX this week. The INDEX has been published quarterly since 2009 and ranks the websites of nearly 200 companies based on User Experience, Search Engine Optimisation and Governance, Risk and Compliance.

Our Q2 2020 INDEX was produced on 13th April 2020 and in its preparation, we ran over 95 million tests checks and measures across over 290,000 URLs.

Congratulations go to Apotex for retaining first place. Also, congratulations are due to Alexion Pharmaceuticals for being the most improved.

If we focus purely on Accessibility, then we see that

  • Only 3 companies scored 7 or higher.
  • 85% scored 4 or less.
  • 36% actually scored zero

Comparing results with last quarter, only 23 companies improved their accessibility score from the last quarter, while 15 scored lower. 8 companies failed all of the WCAG 2.1 Level A and AA tests on every single page.

Making websites accessible is law - in the US there is the Americans with Disabilities Act (ADA) and in the UK the Equalities Act 2000.

The Top Ten Global Life Sciences Websites

  1. Apotex
  2. Medivir Group
  3. Ligand Pharmaceuticals
  4. Dainippon Sumitomo
  5. SOBI
  6. United Therapeutics
  7. Stallergenes
  8. Xoma
  9. Yakult UK
  10. Kyorin Holdings

Five Most Improved

  • Alexion Pharmaceuticals
  • Hisamitsu
  • Esteve
  • Vernalis
  • Piramel Enterprises

The full 2020 Q2 Global Life Sciences results can be found here: Sitemorse Global Life Sciences INDEX